Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 9/13/2025Denovo's Publishes Landmark Trial in Precision Psychiatry in JAMA
  • 9/12/2025China Approves FirboX's Fibroblast-Based Therapy for Clinical Trials
  • 9/11/2025Novartis Gains Expanded Approval for Tabrecta in China
  • 9/11/2025Henlius' HLX43 Shows Promising Results in Phase I Trial
  • 9/11/2025IDEAYA's IDE849 Shows Strong Results in Phase I Trial
  • 9/9/2025RemeGen's Telitacicept Advances in Sjögren's Syndrome
  • 9/9/2025BioNTech and BMS Report Promising Global Phase II Data for Pumitamig
  • 9/8/2025Junshi Achieves Positive Phase 3 Results for JS005 in Psoriasis Treatm...
  • 9/8/2025Innovent's Tigulixostat Demonstrates Superior Efficacy in Phase 2 Gout...
  • 9/8/2025Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...
  • 9/8/2025Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...
  • 9/8/2025Avadel Partners with XWPharma to Advance Valiloxybate for Sleep Disord...
  • 9/5/2025Yangtze River's Fexuprazan Gains Chinese Approval
  • 9/5/20253SBio Secures IND Nod for Dual-Target CAR-T Therapy SA102
  • 9/5/2025BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...
  • 9/4/2025Baili-Bio Launches Phase 3 Trial for HER2-Targeted ADC in Gastric Canc...
  • 9/3/2025Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...
  • 9/2/2025Nine First-in-Class Drugs Receive Initial Clinical Approval in China
  • 9/2/2025China Approved Seven New Drugs in August
  • 9/1/2025BioNTech Launches Phase 1/2 Trial of BNT327 and BNT3212 in Advanced Tu...
  • 9/1/2025Hongcheng Launches Phase II Trial for PD-1/CTLA-4/VEGF TsAb in Advance...
  • 9/1/2025Novel iPSC-Derived Neural Cell Therapy Shows Promise in SCI Treatment
  • 9/1/2025Hengrui Seeks NMPA Approval for New Dual-Receptor Obesity Drug HRS9531
  • 8/30/2025CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib
  • 8/29/2025D3 Bio's D3S-001 Receives FDA Breakthru Therapy and Orphan Drug Design...
  • 8/29/2025Boehringer's Zongertinib Gains Conditional Approval in China
  • 8/29/2025Hengrui's SHR2554 Receives Conditional NMPA Approval
  • 8/29/2025Akeso Advances First Bispecific ADC Into Clinical Stage With First Pat...
  • 8/26/2025Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...
  • 8/26/2025Arnatar Debuts with FDA Designations for Alagille Syndrome Candidate A...
  • Page:1/19 Total number of articles:568: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group